LCK JNK 1 LLC - Feb 9, 2025 Form SCHEDULE 13G/A Schedule Report for Scinai Immunotherapeutics Ltd.

Filing Manager: LCK JNK 1 LLC
Reporting Manager: LCK JNK 1 LLC
Security: Scinai Immunotherapeutics Ltd. American Depository Shares, each representing 4,000 Ordinary Shares, no par value
Shares outstanding: 850K shares
Disclosed Ownership: 80.8K shares
Ownership: 9.5%
Form type: SCHEDULE 13G/A
Date filed: 3/4/2025, 09:58 PM
Date of event: Feb 9, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
LCK JNK 1 LLC	9.5%	80.8K	80.8K	0	/s/ Richard J. Kertzman	Richard J. Kertzman, Sole Member